HPRNA: Predicting synergistic drug combinations for angina pectoris based on human pathway relationship network...

Area of Science:

• Computational biology
• Pharmacology
• Bioinformatics

Background:

• Synergistic drug combinations enhance treatment efficacy and reduce toxicity.
• Predicting these combinations computationally is more efficient than experimental screening.

Purpose of the Study:

• To introduce a novel algorithm, the Human Pathway Relationship Network Algorithm (HPRNA), for predicting synergistic drug combinations.
• To apply HPRNA to the prediction of drug combinations for angina pectoris.

Main Methods:

• Reconstructed an angina pectoris drug dataset including drug metabolism, chemical formulas, targets, and pathways.
• Constructed a human pathway network based on genetic similarity of target-containing pathways.
• Developed a novel indicator to calculate drug pair scores for synergy likelihood.

Main Results:

• The HPRNA effectively utilizes target and pathway information.
• The algorithm demonstrated superior performance compared to existing methods in predicting synergistic drug combinations for angina pectoris.

Conclusions:

• The HPRNA is an efficient and effective tool for predicting synergistic drug combinations.
• This computational approach holds significant promise for advancing angina pectoris treatment.